论文部分内容阅读
自实行献血员乙型肝炎表面抗原筛选以来,输血后乙型肝炎的发生率明显减少,约占输血后肝炎的10-30%。输血后肝炎大部分为非甲非乙型肝炎,本病有转化成肝硬化的危险,采取预防措施实为重要。作者对160例输血的心血管手术患者进行了观察,对照组52人。108例给预防措施,每200m1全血中加入250-500mg静注用免疫球蛋白,混合,静置5分钟后输注,观察8周。输血后肝炎判定标准分三型,Ⅰ型:SGPT或SGOT值高于50U,持续至少2周;Ⅱ型:SGPT或SGOT值高于200U,持续至少2周;Ⅲ型:具有Ⅱ型标准的同时,总胆红素在1.3mg/dl以上者。
Since the implementation of blood donors hepatitis B surface antigen screening, the incidence of hepatitis B after transfusion decreased significantly, accounting for about 10-30% of post-transfusion hepatitis. Most of the post-transfusion hepatitis is non-A, non-B hepatitis. The disease has the risk of transforming into cirrhosis. It is very important to take preventive measures. The authors observed 160 transfusion patients with cardiovascular surgery, control group of 52 people. 108 cases of prophylaxis, per 200m1 whole blood 250-500mg intravenous immunoglobulin, mixed, let stand for 5 minutes after infusion, observation of 8 weeks. Type II: SGPT or SGOT values are higher than 200U for at least 2 weeks; Type III: Type II: SGPT or SGOT values higher than 50U for at least 2 weeks; Type II: , Total bilirubin in 1.3mg / dl above.